Cauterization Versus fibrin Glue for Conjunctival Autografting in Primary Pterygium Surgery

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorUniversity of Split, School of Medicine

About this trial

Pterygium is a noncancerous growth of the conjunctival tissue over the cornea. It is a progressive disease that may lead to visual impairment in advanced stages, as well as restriction of ocular motility, chronic inflammation and cosmetic concerns. Surgical removal is the treatment of choice, but recurrence of pterygium is a frequent problem. In this randomized controlled cauterization will be compared with fibrin glue for conjunctival autografting in primary pterygium surgery.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

adults (older than 18 years of age)

both sexes

primary nasal pterygia ˃4 mm, which tends to increase, including patients with reduced visual acuity, chronic inflammation, cosmetic reasons

if the patients had a bilateral pterygium, only one eye will be operated

Disqualifiers

connective tissue disease

prior eye surgery

chronic use of topical drugs (anti-glaucoma drugs)

Trial design

Design model

Parallel

Treatments tested in this trial

  • Cauterization

    Procedure/Surgery

    To ensure the stability of the graft during cuttings, four sealing wraps will be installed, which will be removed after cauterisation is completed. Autograft and conjunctiva will be approximated by surgical forceps and will be cauterized using a bipolar cutter (Erbe ICC 50) with a force 1-3 / 20. Forceps will be released slowly to prevent elevation of the graft. The same procedure will be performed 10 times until graft is well firmed. Graft stability will be checked up with a sponge and additional cauterization will be preformed if needed.

  • Fibrin glue

    Procedure/Surgery

    Fiber adhesive (Tissel 1 mL kit4-iu) will be prepared according to manufacturer's instructions. Preparation time will be approximately 10-15 min per kit. Once mixed the fibrin glue is usable up to 4 h. For the purpose of the study preparation of the fibrin glue will be performed by a nurse.

Treatment groups

164 Participants
are divided into 2 treatment groups
Group A: CauterizationExperimental treatment 1 intervention
Group B: Fibrin glueActive comparator 1 intervention

Trial outcomes

Primary outcomes

1

Recurrence of pterygium

Any re-growth of tissue from the area of excision across the limbus onto the cornea.

Time frame
180 days

Secondary outcomes

1

Surgical time

Surgical time: total operational time required for completion of the operation (measured in minutes)

Time frame
During the surgery
2

Complication rate

Complication rate will be analyzed as the occurrence of at least one of the following major complications such as dehiscence, displacement or loss of the autograft, infection, haemorrhage, oedema, fibrosis, retraction and other indications that required special treatment

Time frame
7, 30 and 180 days
3

Pterygium-induced astigmatism

Measured as described by Hsu 2014

Time frame
7, 30 and 180 days
4

Ocular surface condition

The Ocular Surface Disease Index (OSDI) is a 12-question validated questionnaire used to measure ocular symptoms, visual function, and environmental factors that may affect a patient's vision. The OSDI scoring scale ranges from 0 to 100. The lower the score, the more symptomatic relief from dry eye symptoms a patient experiences. Baseline-adjusted scores were tabulated; a negative number change from baseline indicates a perceived improvement in ocular comfort.

Time frame
7, 30 and 180 days

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

University of Split, School of Medicine

Lead sponsor

University Hospital of Split

Collaborator